NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-013-2000-0-US-06 PROCESS FOR PREPARING 17alpha-ACETOXY-11beta-(4-N,N-(DIMETHYLAMINO) PHENYL)-21-METHOXY-19-NOREGNA-4,9-DIENE-3,20-DIONE,INTERMEDIATES US National Stage 10/169,139 6768014 Expired PDF
NIAID E-115-2000-0-US-12 Attenuated Human-Bovine Chimeric Parainfluenza Virus (PIV) Vaccines US National Stage 10/030,544 Abandoned
NCI E-114-2001-0-PCT-02 Methods of Generating Human CD4+ Th2 Cells PCT PCT PCT/US02/20415 Expired
NCI E-240-2001-0-PCT-02 Macromolecular Imaging Agents For Liver Imaging PCT PCT PCT/US2002/020118 Expired
NCI E-240-2001-0-EP-03 Macromolecular Imaging Agents For Liver Imaging EP National Stage 02752092.3 Abandoned
NIDDK E-213-2001-2-PCT-01 Vitamin D Receptor Antagonists and Related Compositions and Methods of Use PCT PCT COMB PCT/US02/19774 Expired
NHGRI E-196-2001-0-PCT-02 Use of Interferon-inducible 2',5'-Oligoadenylate-dependent RNase L in The Diagnosis, Prognosis And Treatment of Cancer PCT PCT PCT/US02/19516 Expired
NCI E-059-2001-1-US-01 Transforming Growth Factor Beta(TGF-BETA) Antagonist Selectively Neutralize PATHOLOGICAL TGF BETA. US ORD 10/176,266 Abandoned
NCI E-022-1998-0-US-06 ALKENYLDIARYLMETHANE NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHBIBITORS (NNRTIS) US National Stage 09/581,927 6569897 Abandoned PDF
NCI E-072-1999-0-US-03 Transition Metal Complexes of N ,N',N-Trialkyl-CIS,CIS-1,3,5- Triaminocyclohexane & Related Compositions & Methods of Synthesis... US National Stage 10/049,115 6765104 Abandoned PDF
NCI E-058-2001-0-PCT-02 Human UGRP (Uteroglobin-Related Protein) 1 Promoter And its Use PCT PCT PCT/US02/19456 Expired
NIAID E-122-2001-0-PCT-02 Anti-Arthropod Vector Vaccines,Methods of Selecting and Uses Thereof PCT PCT PCT/US02/19663 Expired
NIAID E-122-2001-0-EP-03 Anti-Arthropod Vector Vaccines, Methods of Selecting and Uses Thereof EP National Stage 02752074.1 Abandoned
NIAID E-122-2001-0-BR-06 Anti-Arthropod Vector Vaccines, Methods of Selecting and Uses Thereof BR National Stage PI0210539-0 Abandoned
NIAID E-122-2001-0-MX-07 Anti-Arthropod Vector Vaccines, Methods of Selecting and Uses Thereof MX National Stage PA/A/2004/00005 Abandoned
NIAID E-131-2002-0-JP-11 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NKT CELLS JP DIV 2010-85587 Abandoned
NIAID E-131-2002-0-GB-25 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS GB EP 10184017.1 Abandoned
NIAID E-131-2002-0-FR-24 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS FR EP 10184017.1 Abandoned
NIAID E-131-2002-0-DE-22 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS DE EP 10184017.1 Abandoned
NIAID E-131-2002-0-IT-26 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS IT EP 10184017.1 Abandoned
NIAID E-131-2002-0-EP-12 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS EP DIV 10184017.1 Abandoned
NIAID E-131-2002-0-ES-23 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS ES EP 10184017.1 Abandoned
NIAID E-131-2002-0-CH-21 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS CH EP 10184017.1 Abandoned
NIAID E-131-2002-0-ES-15 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS ES EP 02742057.9 Abandoned
NIAID E-131-2002-0-CH-13 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS CH EP 02742057.9 Abandoned
NIAID E-131-2002-0-FR-16 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS FR EP 02742057.9 Abandoned
NIAID E-131-2002-0-DE-14 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS DE EP 02742057.9 Abandoned
NIAID E-131-2002-0-GB-17 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS GB EP 02742057.9 Abandoned
NIAID E-131-2002-0-EP-08 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS EP National Stage 02742057.9 Abandoned
NIAID E-131-2002-0-IT-18 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS IT EP 02742057.9 Abandoned
NIAID E-131-2002-0-JP-04 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS JP National Stage 2004-515561 Abandoned
NIAID E-131-2002-0-AU-05 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS;mn AU National Stage 2002315115 Abandoned
NIAID E-131-2002-0-NZ-06 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS NZ National Stage 537726 Abandoned
NIAID E-131-2002-0-ZA-07 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS ZA National Stage 2005/00375 Abandoned
NIAID E-131-2002-0-PCT-01 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS PCT PCT PCT/US2002/018790 Abandoned
NCI E-221-2001-0-PCT-02 PATE, A Gene Expressed in Prostate Cancer, Prostate And Testis, And Uses Thereof PCT PCT PCT/US02/19086 Expired
NIAID E-131-2002-0-JP-27 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NKT CELLS JP DIV 2012-186893 Abandoned
NIAID E-131-2002-0-HK-09 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS HK National Stage 05112119.6 Abandoned
NIAID E-131-2002-0-CA-03 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS CA National Stage 2489540 Abandoned
NIEHS E-183-1999-0-US-07 HUMAN P53 MUTATION AND A GENETIC SYSTEM IN YEAST FOR FUNCTIONAL IDENTI FICATION OF HUMAN P53 MUTATIONS US National Stage 10/048,502 7256260 Abandoned PDF
NIMH E-079-2001-0-PCT-02 Use of The Parathyroid Hormone-2(PTH2) Receptor to Screen For Agents to Treat Pain PCT PCT PCT/US02/18771 Expired
NHLBI E-265-2000-0-US-02 MAMMALIAN POLYPEPTIDES AND POLYNUCLEOTIDES US CON 10/183,039 Abandoned
NCI E-033-1999-0-US-03 High Speed Parallel Molecular Nucleic Acid Sequencing US National Stage 10/070,053 6982146 Abandoned PDF
NHGRI E-167-2001-2-US-01 Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium US CIP 11/162,796 Expired
NICHD E-010-1998-1-AU-03 The Protein Tyrosine Kinase Substrate LAT and Its Use in the Identification of (Ant) Agonists of the Kinase AU DIV 45788/02 Abandoned
NHGRI E-324-2001-1-US-01 SELECTIONS OF GENES AND METHODS OF USING THE SAME FOR DIAGNOSIS AND FOR TARGETING THE THERAPY OF SELECT CANCERS US CIP 10/159,563 7655397 Abandoned PDF
NCI E-148-1998-1-JP-07 Molecular Clones With Mutated HIV GAG/POL and SIV GAG and SIV ENV Genes JP National Stage 2003-502211 Abandoned
NCI E-148-1998-1-AU-08 Molecular Clones With Mutated HIV GAG/POL and SIV GAG and SIV ENV Genes AU National Stage 2002303934 Abandoned
NCI E-148-1998-1-PCT-02 Molecular Clones With Mutated HIV GAG/POL and SIV GAG and SIV ENV Genes PCT PCT PCT/US2002/017258 Expired
NCI E-148-1998-1-EP-06 Molecular Clones With Mutated HIV GAG/POL and SIV GAG and SIV ENV Genes EP National Stage 02732000.1 Abandoned